5. Conclusion
Our study concluded that PPCI is the most significant predic-
tor for in-hospital adverse events of mortality in STEMI patients.
Patients underwent early and delayed PPCI demonstrated substantially
lower mortality rate compared with optimal medical therapy group,
with early PPCI group shown the lowest mortality rate. PPCI was also a
strong predictor for immediate lethal cardiovascular complications eg.
Cardiogenic shock, cardiac arrest, and VT/VF rhythm. Finally, non
revascularized patients had significantly higher treatment cost
compared with patients receiving PPCI.
6. Declarations
6.1. Ethics Approval and Consent to participate
This study was approved by local Institutional Review Board, and all
participants have provided written informed consent prior to involve-
ment in the study.
6.2. Consent for publication
Not applicable.
6.3. Availability of data and materials
Data used in our study were presented in the main text.
6.4. Competing interests
Not applicable.
6.5. Funding source
Not applicable.
Table 4.5 Multivariate analysis of coefficient related to mortality
Variables
Killip
Revascularization Category
Culprit lesion
TIMI Flow
Coeficcient
1.180
2.410
2.055
HR
3.256
4.506
1.348
0.853
P Value
0.00*
0.00*
0.004*
0.151
Note. HR = hazard ratio; 95% CI = 95% confidence interval; TIMI = thrombosis in myocardial infarction study group
95% CI
2.088-5.078
2.487-6.662
1.169-1.717
0.687-1.059
6.6. Authors contributions
Idea/concept: AS. Design: AS, MSR. Control/supervision: MSR, AR, SA,
HM, IP. Literature search: AS, MSR. Data extraction: AS, MSR. Statisti-
cal analysis: AS, MSR. Results interpretation: AS, MSR. Critical
review/discussion: MSR, AR, SA, HM, IP. Writing the article: AS. All
authors have critically reviewed and approved the final draft and are
responsible for the content and similarity index of the manuscript.
6.7. Acknowledgements
We thank to Brawijaya Cardiovascular Research Center.
Chia sẻ với bạn bè của bạn: |